Reckitt CEO's $17B Predicament Post author:Sam Post published:December 26, 2017 Post category:BioPharma 2018 is the year for Rakesh Kapoor to show he’s worth it. Source: BioSpace You Might Also Like 2 Biotechs That May Disappear by 2020 March 30, 2017 <b>PharmaSeek</b> Offers Solution to Slow Payments In The Clinical Research Industry October 4, 2017 3rd Stemline Patient Died in Clinical Trial One Day Before $45 Million Public Offering February 1, 2017
3rd Stemline Patient Died in Clinical Trial One Day Before $45 Million Public Offering February 1, 2017
